Treatment of mild-to-moderate pelvic inflammatory disease with a short-course azithromycin-based regimen versus ofloxacin plus metronidazole: Results of a multicentre, randomised controlled trial

Gillian Dean*, Suneeta Soni, Rachel Pitt, Jonathan Ross, Caroline Sabin, Jennifer Whetham

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    3 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)177-182
    Number of pages6
    JournalSexually Transmitted Infections
    Volume97
    Issue number3
    DOIs
    Publication statusPublished (VoR) - 1 May 2021

    Keywords

    • azithromycin
    • mycoplasma
    • pelvic inflammatory disease

    Fingerprint

    Dive into the research topics of 'Treatment of mild-to-moderate pelvic inflammatory disease with a short-course azithromycin-based regimen versus ofloxacin plus metronidazole: Results of a multicentre, randomised controlled trial'. Together they form a unique fingerprint.

    Cite this